CME250117C200000
- 33.40
- 0.000.00%
CME Group Newsroom
CME Group Cut to Neutral From Buy by Citigroup
RBC Capital Sticks to Their Hold Rating for CME Group (CME)
CME Gr Analyst Ratings
Citi Downgrades CME Group(CME.US) to Hold Rating, Cuts Target Price to $250
Cautious Hold on CME Group Amid Market Volatility and Future Growth Slowdown
Analysts Offer Insights on Financial Companies: Franklin Resources (BEN) and CME Group (CME)
Citigroup Downgrades CME to Neutral From Buy, Adjusts Price Target to $250 From $255
Analysts' Opinions Are Mixed on These Financial Stocks: US Bancorp (USB) and CME Group (CME)
Barclays Maintains CME Group(CME.US) With Hold Rating, Maintains Target Price $257
KBW Maintains CME Group(CME.US) With Hold Rating, Raises Target Price to $260
TD Cowen Maintains CME Group(CME.US) With Hold Rating, Raises Target Price to $257
CME Gr Analyst Ratings
TD Cowen Adjusts Price Target on CME Group to $257 From $239
Barclays Maintains CME Group(CME.US) With Hold Rating, Maintains Target Price $257
Barclays Remains a Hold on CME Group (CME)
KBW Maintains CME Group(CME.US) With Hold Rating, Raises Target Price to $237
Barclays Maintains CME Group(CME.US) With Hold Rating, Maintains Target Price $257
Barclays Reaffirms Their Hold Rating on CME Group (CME)
CME Group Is Maintained at Equal-Weight by Barclays
CME Gr Analyst Ratings